Hemangiomas in Children

To the Editor: In their otherwise thoughtful and informative article, Drolet and colleagues (July 15 issue) 1 dismiss intralesional corticosteroid injection in the treatment of juvenile periocular hemangiomas as “contraindicated, since it is fraught with complications.” I am surprised at this statem...

Full description

Saved in:

Bibliographic Details
Published in:	The New England journal of medicine Vol. 341; no. 26; pp. 2018 - 2019
Main Author:	Kushner, B J
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 23-12-1999
Subjects:	Adrenal Cortex Hormones - adverse effects Adrenal Cortex Hormones - therapeutic use Child Eye Neoplasms - drug therapy Hemangioma - drug therapy Humans Injections, Intralesional
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To the Editor: In their otherwise thoughtful and informative article, Drolet and colleagues (July 15 issue) 1 dismiss intralesional corticosteroid injection in the treatment of juvenile periocular hemangiomas as “contraindicated, since it is fraught with complications.” I am surprised at this statement, since I believe that intralesional corticosteroids are considered the treatment of choice by a large number of pediatric ophthalmologists and oculoplastic surgeons. 2 – 5 The statement “fraught with complications” is misleading because it implies a high frequency of complications. However, the authors cite only several case reports of complications; no incidence is given. In fact, serious complications occur infrequently with . . .
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJM199912233412614